Latest Advances in Human Papillomavirus (HPV) Research
A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Viral Pathogens".
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 22225
Special Issue Editors
Interests: human papillomavirus vaccines; immunogenicity; correlates of protection
Special Issues, Collections and Topics in MDPI journals
Interests: infection; immunity; global health
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Human papillomavirus (HPV) causes a range of diseases from benign anogenital warts to anogenital cancers, particularly cervical cancer. HPV was first discovered to cause cervical cancer in the 1980s, and since then, there have been several major scientific breakthroughs that have led to the development and implementation of highly effective prophylactic HPV vaccines, cervical cancer screening programs, and treatment of cervical lesions. These important discoveries build upon key basic science research and technological advancement that has enabled novel discoveries within HPV research. In 2018, the Director-General of the World Health Organization made a pledge to eliminate cervical cancer as a public health problem within the next century and outlined a strategy encompassing HPV vaccination, screening, and treatment. However, significant barriers remain to cervical cancer elimination globally, and research into novel HPV diagnostics and therapeutics as well as intervention research will be important to overcome these barriers. This Special Issue aims to present the latest research into HPV in the hope that it will contribute new knowledge to the field as well as ultimately aid in achieving the cervical cancer elimination goal.
Dr. Paul Licciardi
Dr. Zheng Quan Toh
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- human papillomavirus
- vaccine
- immune response
- pathogenesis
- cervical cancer screening
- treatment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.